<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/945"/><api:result><api:object category="publication" id="945" last-affected-when="2024-04-15T00:59:42.66+01:00" last-modified-when="2024-04-15T00:59:42.66+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/945" created-when="2010-05-17T13:47:28.04+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2000-04-13</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1492085" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1086/315376" last-modified-when="2022-09-10T12:21:40.543+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Simms</api:last-name><api:initials>JR</api:initials><api:first-names>JR</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1086/315376</api:text><api:links><api:link type="doi" href="http://doi.org/10.1086/315376"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1086/315376"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1537-6613</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974106"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-1899</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974106"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The Journal of Infectious Diseases</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1240</api:begin-page><api:end-page>1248</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Oxford University Press (OUP)</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1086/315376</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>23</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Use of Herpes Simplex Virus (HSV) Type 1 ISCOMS 703 Vaccine for Prophylactic and Therapeutic Treatment of Primary and Recurrent HSV‚Äê2 Infection in Guinea Pigs</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>181</api:text></api:field></api:native></api:record><api:record format="native" id="95812" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0034022518" last-modified-when="2023-03-01T04:21:38.96+00:00"><api:citation-count>23</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The effect of subunit vaccination on the incidence and severity of primary and recurrent genital herpes was investigated in the female guinea pig model of herpes simplex virus (HSV) type 2 genital infection. After prophylactic immunization with zwitterionic detergent-solubilized HSV-1 glycoproteins formulated with alhydrogel or as immunostimulating complex particles, significant reductions in the incidence and severity of primary herpetic illness were observed in both vaccinated groups compared with immunization-naive controls. There was a significant reduction in the incidence of spontaneous herpetic recurrences after administration of HSV-1 antigens formulated as immunostimulatory complexes to guinea pigs in a prophylactic mode (P&lt;.01). Increased levels of both postimmunization and postchallenge ELISA and neutralizing antibodies were significant correlates of protection against primary herpetic disease in a prophylactic scenario. However, no correlation was observed between elevated ELISA or neutralizing antibody levels and protection against recurrent disease following prophylactic or therapeutic administration of HSV-1 subunit vaccines.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Simms</api:last-name><api:initials>JR</api:initials><api:first-names>JR</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="US"><api:line type="organisation">City of Hope National Med Center</api:line><api:line type="city">Duarte</api:line><api:line type="country">United States</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">36837186500</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7201835305</api:identifier></api:identifiers></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7201971819</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1086/315376</api:text><api:links><api:link type="doi" href="http://doi.org/10.1086/315376"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1086/315376"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10762560</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-1899</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974106"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Infectious Diseases</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1240</api:begin-page><api:end-page>1248</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>22</api:day><api:month>5</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>181</api:text></api:field></api:native></api:record><api:record format="native" id="945" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10762560" last-modified-when="2020-04-29T05:33:49.117+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The effect of subunit vaccination on the incidence and severity of primary and recurrent genital herpes was investigated in the female guinea pig model of herpes simplex virus (HSV) type 2 genital infection. After prophylactic immunization with zwitterionic detergent-solubilized HSV-1 glycoproteins formulated with alhydrogel or as immunostimulating complex particles, significant reductions in the incidence and severity of primary herpetic illness were observed in both vaccinated groups compared with immunization-naive controls. There was a significant reduction in the incidence of spontaneous herpetic recurrences after administration of HSV-1 antigens formulated as immunostimulatory complexes to guinea pigs in a prophylactic mode (P&lt;.01). Increased levels of both postimmunization and postchallenge ELISA and neutralizing antibodies were significant correlates of protection against primary herpetic disease in a prophylactic scenario. However, no correlation was observed between elevated ELISA or neutralizing antibody levels and protection against recurrent disease following prophylactic or therapeutic administration of HSV-1 subunit vaccines.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Simms</api:last-name><api:initials>JR</api:initials><api:first-names>JR</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Sheffield Institute for Vaccine Studies, Division of Molecular and Genetic Medicine, Section of Infection and Immunity, University of Sheffield Medical School, Sheffield, United Kingdom. john_simms@coh.org</api:line></api:address></api:addresses><api:email-address>john_simms@coh.org</api:email-address></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10762560</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1086/315376</api:text><api:links><api:link type="doi" href="http://doi.org/10.1086/315376"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1086/315376"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-1899</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974106"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J Infect Dis</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Adjuvants, Immunologic</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Antibodies, Viral</api:keyword><api:keyword scheme="mesh">Antigens, Viral</api:keyword><api:keyword scheme="mesh">Chlorocebus aethiops</api:keyword><api:keyword scheme="mesh">Disease Models, Animal</api:keyword><api:keyword scheme="mesh">Enzyme-Linked Immunosorbent Assay</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Guinea Pigs</api:keyword><api:keyword scheme="mesh">Herpes Genitalis</api:keyword><api:keyword scheme="mesh">Herpesvirus 1, Human</api:keyword><api:keyword scheme="mesh">Herpesvirus 2, Human</api:keyword><api:keyword scheme="mesh">ISCOMs</api:keyword><api:keyword scheme="mesh">Neutralization Tests</api:keyword><api:keyword scheme="mesh">Secondary Prevention</api:keyword><api:keyword scheme="mesh">Vero Cells</api:keyword><api:keyword scheme="mesh">Viral Vaccines</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1240</api:begin-page><api:end-page>1248</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>JID991026</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>1</api:day><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>181</api:text></api:field></api:native></api:record><api:record format="native" id="882155" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10762560" last-modified-when="2022-09-13T17:52:27.247+01:00"><api:citation-count>12</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The effect of subunit vaccination on the incidence and severity of primary and recurrent genital herpes was investigated in the female guinea pig model of herpes simplex virus (HSV) type 2 genital infection. After prophylactic immunization with zwitterionic detergent-solubilized HSV-1 glycoproteins formulated with alhydrogel or as immunostimulating complex particles, significant reductions in the incidence and severity of primary herpetic illness were observed in both vaccinated groups compared with immunization-naive controls. There was a significant reduction in the incidence of spontaneous herpetic recurrences after administration of HSV-1 antigens formulated as immunostimulatory complexes to guinea pigs in a prophylactic mode (P&lt;.01). Increased levels of both postimmunization and postchallenge ELISA and neutralizing antibodies were significant correlates of protection against primary herpetic disease in a prophylactic scenario. However, no correlation was observed between elevated ELISA or neutralizing antibody levels and protection against recurrent disease following prophylactic or therapeutic administration of HSV-1 subunit vaccines.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Sheffield Institute for Vaccine Studies, Division of Molecular and Genetic Medicine, Section of Infection and Immunity, University of Sheffield Medical School, Sheffield, United Kingdom. john_simms@coh.org</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Simms</api:last-name><api:initials>JR</api:initials><api:first-names>JR</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1086/315376</api:text><api:links><api:link type="doi" href="http://doi.org/10.1086/315376"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1086/315376"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1537-6613</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974106"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10762560</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-1899</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974106"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The Journal of infectious diseases</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Vero Cells</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Guinea Pigs</api:keyword><api:keyword scheme="mesh">Herpesvirus 1, Human</api:keyword><api:keyword scheme="mesh">Herpesvirus 2, Human</api:keyword><api:keyword scheme="mesh">Herpes Genitalis</api:keyword><api:keyword scheme="mesh">Disease Models, Animal</api:keyword><api:keyword scheme="mesh">ISCOMs</api:keyword><api:keyword scheme="mesh">Viral Vaccines</api:keyword><api:keyword scheme="mesh">Adjuvants, Immunologic</api:keyword><api:keyword scheme="mesh">Antibodies, Viral</api:keyword><api:keyword scheme="mesh">Antigens, Viral</api:keyword><api:keyword scheme="mesh">Enzyme-Linked Immunosorbent Assay</api:keyword><api:keyword scheme="mesh">Neutralization Tests</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Secondary Prevention</api:keyword><api:keyword scheme="mesh">Chlorocebus aethiops</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>13</api:day><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1240</api:begin-page><api:end-page>1248</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>14</api:day><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>181</api:text></api:field></api:native></api:record><api:record format="native" id="2506971" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1023126591" last-modified-when="2024-04-15T00:59:42.663+01:00"><api:citation-count>24</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>3</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Simms</api:last-name><api:initials>JR</api:initials><api:first-names>JR</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01300665515.44</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0657140264.85</api:identifier></api:identifiers></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01164605622.09</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1086/315376</api:text><api:links><api:link type="doi" href="http://doi.org/10.1086/315376"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1086/315376"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10762560</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>2</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-1899</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974106"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The Journal of Infectious Diseases</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3207 Medical Microbiology</api:keyword><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3204 Immunology</api:keyword><api:keyword scheme="rcdc">Infectious Diseases</api:keyword><api:keyword scheme="rcdc">Prevention</api:keyword><api:keyword scheme="rcdc">Biotechnology</api:keyword><api:keyword scheme="rcdc">Sexually Transmitted Infections</api:keyword><api:keyword scheme="rcdc">Immunization</api:keyword><api:keyword scheme="rcdc">Vaccine Related</api:keyword><api:keyword scheme="hrcs-rac">3 Prevention of disease and conditions, and promotion of well-being</api:keyword><api:keyword scheme="hrcs-rac">3.4 Vaccines</api:keyword><api:keyword scheme="hrcs-hc">Infection</api:keyword><api:keyword scheme="sdg">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh">Adjuvants, Immunologic</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Antibodies, Viral</api:keyword><api:keyword scheme="mesh">Antigens, Viral</api:keyword><api:keyword scheme="mesh">Chlorocebus aethiops</api:keyword><api:keyword scheme="mesh">Disease Models, Animal</api:keyword><api:keyword scheme="mesh">Enzyme-Linked Immunosorbent Assay</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Guinea Pigs</api:keyword><api:keyword scheme="mesh">Herpes Genitalis</api:keyword><api:keyword scheme="mesh">Herpesvirus 1, Human</api:keyword><api:keyword scheme="mesh">Herpesvirus 2, Human</api:keyword><api:keyword scheme="mesh">ISCOMs</api:keyword><api:keyword scheme="mesh">Neutralization Tests</api:keyword><api:keyword scheme="mesh">Secondary Prevention</api:keyword><api:keyword scheme="mesh">Vero Cells</api:keyword><api:keyword scheme="mesh">Viral Vaccines</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>13</api:day><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Bronze OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1240</api:begin-page><api:end-page>1248</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Oxford University Press (OUP)</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.41</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Use of Herpes Simplex Virus (HSV) Type 1 ISCOMS 703 Vaccine for Prophylactic and Therapeutic Treatment of Primary and Recurrent HSV-2 Infection in Guinea Pigs</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>181</api:text></api:field></api:native></api:record><api:record format="native" id="241606" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000086883900003" last-modified-when="2024-03-14T05:58:13.737+00:00"><api:citation-count>21</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Simms</api:last-name><api:initials>JR</api:initials><api:first-names>JR</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000086883900003&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1086/315376</api:text><api:links><api:link type="doi" href="http://doi.org/10.1086/315376"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1086/315376"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1537-6613</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974106"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">311KT</api:identifier><api:identifier scheme="pubmed">10762560</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-1899</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974106"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>JOURNAL OF INFECTIOUS DISEASES</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1240</api:begin-page><api:end-page>1248</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection inn guinea pigs</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>181</api:text></api:field></api:native></api:record><api:record format="native" id="24675" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000086883900003" last-modified-when="2014-07-25T11:06:35.873+01:00"><api:citation-count>15</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Simms</api:last-name><api:initials>JR</api:initials><api:first-names>JR</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-1899</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974106"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J INFECT DIS</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>RECOMBINANT GLYCOPROTEIN-D</api:keyword><api:keyword>G FC-RECEPTOR</api:keyword><api:keyword>GENITAL HERPES</api:keyword><api:keyword>IMMUNOGLOBULIN-G</api:keyword><api:keyword>IMMUNOSTIMULATING COMPLEXES</api:keyword><api:keyword>PARENTERAL IMMUNIZATION</api:keyword><api:keyword>VAGINAL INFECTION</api:keyword><api:keyword>ANTIBODY-RESPONSE</api:keyword><api:keyword>SUBUNIT VACCINES</api:keyword><api:keyword>HUMORAL IMMUNITY</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1240</api:begin-page><api:end-page>1248</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection inn guinea pigs</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>181</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adjuvants, Immunologic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antibodies, Viral</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antigens, Viral</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Chlorocebus aethiops</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Disease Models, Animal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Enzyme-Linked Immunosorbent Assay</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Guinea Pigs</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Herpes Genitalis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Herpesvirus 1, Human</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Herpesvirus 2, Human</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">ISCOMs</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Neutralization Tests</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Secondary Prevention</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Vero Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Viral Vaccines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Vero Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Guinea Pigs</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Herpesvirus 1, Human</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Herpesvirus 2, Human</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Herpes Genitalis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Disease Models, Animal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">ISCOMs</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Viral Vaccines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adjuvants, Immunologic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antibodies, Viral</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antigens, Viral</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Enzyme-Linked Immunosorbent Assay</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Neutralization Tests</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Secondary Prevention</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Chlorocebus aethiops</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3207 Medical Microbiology</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3204 Immunology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Infectious Diseases</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Prevention</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Biotechnology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Sexually Transmitted Infections</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Immunization</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Vaccine Related</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">3 Prevention of disease and conditions, and promotion of well-being</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">3.4 Vaccines</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Infection</api:keyword><api:keyword scheme="sdg" origin="record-data" source="dimensions">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adjuvants, Immunologic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antibodies, Viral</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antigens, Viral</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Chlorocebus aethiops</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Disease Models, Animal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Enzyme-Linked Immunosorbent Assay</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Guinea Pigs</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Herpes Genitalis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Herpesvirus 1, Human</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Herpesvirus 2, Human</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">ISCOMs</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Neutralization Tests</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Secondary Prevention</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Vero Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Viral Vaccines</api:keyword><api:keyword origin="record-data" source="wos">RECOMBINANT GLYCOPROTEIN-D</api:keyword><api:keyword origin="record-data" source="wos">G FC-RECEPTOR</api:keyword><api:keyword origin="record-data" source="wos">GENITAL HERPES</api:keyword><api:keyword origin="record-data" source="wos">IMMUNOGLOBULIN-G</api:keyword><api:keyword origin="record-data" source="wos">IMMUNOSTIMULATING COMPLEXES</api:keyword><api:keyword origin="record-data" source="wos">PARENTERAL IMMUNIZATION</api:keyword><api:keyword origin="record-data" source="wos">VAGINAL INFECTION</api:keyword><api:keyword origin="record-data" source="wos">ANTIBODY-RESPONSE</api:keyword><api:keyword origin="record-data" source="wos">SUBUNIT VACCINES</api:keyword><api:keyword origin="record-data" source="wos">HUMORAL IMMUNITY</api:keyword><api:keyword scheme="for" origin="issn-inferred">06 Biological Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">11 Medical and Health Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Microbiology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">31 Biological sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">32 Biomedical and clinical sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">42 Health sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0022-1899" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974106" title="Journal of Infectious Diseases"><api:records><api:record source-name="summary"><api:title>Journal of Infectious Diseases</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/945/relationships"/></api:object></api:result></api:response>